Emanuela Ricotti

973 total citations
22 papers, 681 citations indexed

About

Emanuela Ricotti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Emanuela Ricotti has authored 22 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Emanuela Ricotti's work include Ubiquitin and proteasome pathways (4 papers), Neuroblastoma Research and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). Emanuela Ricotti is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Neuroblastoma Research and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). Emanuela Ricotti collaborates with scholars based in Italy and United States. Emanuela Ricotti's co-authors include Giuseppe Basso, Pier‐Angelo Tovo, M. Rinaudo, Marco Piccinini, Michael Mostert, Alessandro Amore, Nicoletta Crescenzio, Emanuela Garelli, Steven N. Emancipator and Paola Cirina and has published in prestigious journals such as Blood, Hepatology and Biochemical Journal.

In The Last Decade

Emanuela Ricotti

22 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuela Ricotti Italy 14 168 156 116 103 98 22 681
Dolores Subirá Spain 15 144 0.9× 178 1.1× 116 1.0× 211 2.0× 160 1.6× 40 860
Pamela Kimball United States 18 208 1.2× 128 0.8× 169 1.5× 55 0.5× 116 1.2× 56 1.0k
Giuseppe Aimo Italy 16 92 0.5× 204 1.3× 108 0.9× 90 0.9× 74 0.8× 44 749
Colette Chapuis‐Cellier France 15 150 0.9× 111 0.7× 157 1.4× 100 1.0× 41 0.4× 40 604
Shingo Tanaka Japan 19 177 1.1× 160 1.0× 125 1.1× 64 0.6× 207 2.1× 68 904
Anand Ghanekar Canada 14 235 1.4× 141 0.9× 71 0.6× 79 0.8× 173 1.8× 28 845
S. Casanova Italy 16 224 1.3× 120 0.8× 115 1.0× 121 1.2× 193 2.0× 38 1.0k
Karel Kithier United States 15 213 1.3× 106 0.7× 102 0.9× 82 0.8× 85 0.9× 41 778
Norio Hirabayashi Japan 14 132 0.8× 89 0.6× 158 1.4× 349 3.4× 144 1.5× 41 820
G. Monga Italy 18 220 1.3× 77 0.5× 123 1.1× 58 0.6× 199 2.0× 54 948

Countries citing papers authored by Emanuela Ricotti

Since Specialization
Citations

This map shows the geographic impact of Emanuela Ricotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Ricotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Ricotti more than expected).

Fields of papers citing papers by Emanuela Ricotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Ricotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Ricotti. The network helps show where Emanuela Ricotti may publish in the future.

Co-authorship network of co-authors of Emanuela Ricotti

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Ricotti. A scholar is included among the top collaborators of Emanuela Ricotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Ricotti. Emanuela Ricotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Licciardi, Francesco, Marco Denina, Emanuela Ricotti, et al.. (2020). Peculiar immunophenotypic signature in MIS‐C‐affected children. Pediatric Allergy and Immunology. 32(4). 801–804. 3 indexed citations
2.
Licciardi, Francesco, et al.. (2017). Low synovial double negative T and γδ T cells predict longer free‐disease survival in oligoarticular JIA. Cytometry Part B Clinical Cytometry. 94(3). 423–427. 2 indexed citations
3.
Lupino, Elisa, Barbara Buccinnà, Cristina Ramondetti, et al.. (2010). In CD28‐costimulated human naïve CD4+ T cells, I‐κB kinase controls the expression of cell cycle regulatory proteins via interleukin‐2‐independent mechanisms. Immunology. 131(2). 231–241. 6 indexed citations
4.
Coppo, Rosanna, Valentina Fonsato, Emanuela Ricotti, et al.. (2009). Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney International. 77(5). 417–427. 51 indexed citations
5.
Delmonte, Ottavia M., et al.. (2007). Immunomodulatory effects of two HIV protease inhibitors, Saquinavir and Ritonavir, on lymphocytes from healthy seronegative individuals. Immunology Letters. 111(2). 111–115. 8 indexed citations
6.
Kronnie, Geertruy te, Fabio Timeus, Andrea Rinaldi, et al.. (2004). Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition. International Journal of Molecular Medicine. 14(3). 373–82. 17 indexed citations
7.
Piccinini, Marco, M. Rinaudo, Emanuela Ricotti, et al.. (2002). The human 26S proteasome is a target of antiretroviral agents. AIDS. 16(5). 693–700. 64 indexed citations
8.
Granata, Riccarda, Carlotta Gauna, Fabio Broglio, et al.. (2002). H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3).. PubMed. 25(10 Suppl). 44–6. 2 indexed citations
9.
Timeus, Fabio, Emanuela Ricotti, Nicoletta Crescenzio, et al.. (2001). Flt-3 and Its Ligand Are Expressed in Neural Crest–Derived Tumors and Promote Survival and Proliferation of Their Cell Lines. Laboratory Investigation. 81(7). 1025–1037. 21 indexed citations
10.
Piccinini, Marco, Caterina Mezzatesta, Emanuela Ricotti, et al.. (2001). Proteasomes are a target of the anti-tumour drug vinblastine. Biochemical Journal. 356(3). 835–835. 19 indexed citations
11.
Piccinini, Marco, Caterina Mezzatesta, Emanuela Ricotti, et al.. (2001). Proteasomes are a target of the anti-tumour drug vinblastine. Biochemical Journal. 356(3). 835–841. 12 indexed citations
12.
Peruzzi, Licia, Alessandro Amore, Paola Cirina, et al.. (2000). Integrin expression and IgA nephropathy: In vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney International. 58(6). 2331–2340. 25 indexed citations
13.
Amore, Alessandro, et al.. (2000). Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney International. 57(4). 1549–1559. 60 indexed citations
15.
Ricotti, Emanuela, et al.. (1999). Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.. PubMed. 84(10). 879–86. 1 indexed citations
16.
Ricotti, Emanuela, Franca Fagioli, Emanuela Garelli, et al.. (1998). c-kit Is Expressed in Soft Tissue Sarcoma of Neuroectodermic Origin and Its Ligand Prevents Apoptosis of Neoplastic Cells. Blood. 91(7). 2397–2405. 86 indexed citations
17.
Volpe, Gisella, Giuseppe Basso, Enrico Gottardi, et al.. (1997). Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. British Journal of Haematology. 97(2). 460–462. 25 indexed citations
18.
Volpe, Gisella, Giuseppe Basso, Enrico Gottardi, et al.. (1997). The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occurring in children with Down syndrome. Leukemia. 11(6). 820–821. 29 indexed citations
19.
Timeus, Fabio, Nicoletta Crescenzio, Emanuela Garelli, et al.. (1997). Stem cell factor suppresses apoptosis in neuroblastoma cell lines.. PubMed. 25(12). 1253–60. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026